Abstract

RATIONALE: Signaling via the IL-4 receptor alpha chain (IL-4Rα) plays a critical role in the evolution of Th2 responses and the pathology of allergic diseases such as asthma. The IL-4Rα is endowed with an immunoreceptor tyrosine-based inhibitory motif (ITIM) at the fifth tyrosine residue in the cytoplasmic domain of IL-4Rα (Y709). This motif binds a number of SH2-containing phosphatases, including SHP-1, SHP-2, and SHIP. Its role in vivo remains unclear. METHODS: The in vivo function of this ITIM motif in IL-4R signaling was analyzed in mutant mice in which the Y709 residue was mutated into phenylalanine (Y709F) by knockin mutagenesis. RESULTS: B cells from the Y709F mutation demonstrated enhanced Stat6 but not Jak1 phosphorylation following IL-4 stimulation. In vivo, the Y709F mutant mice exhibited increased baseline levels of IgE in the serum and augmented total and antigen-specific IgE responses following immunization. T lymphocytes from this mutation also exhibit significantly increased production of IL-4 in a Th2 polarized milieu. CONCLUSIONS: These results point to a negative regulatory role for the Y709 ITIM motif in signaling via IL-4Rα in vivo. Mutations or polymorphisms that affect ITIM function may play an important role in disease pathogenesis of allergic inflammation such as asthma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.